 | • レポートコード：MRC23Q36276 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（2-3日） • 産業分類：医療 |
| Single User | ￥406,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥812,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界のプラスミドDNA調製市場について調査・分析し、世界のプラスミドDNA調製市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（GMPグレードプラスミドDNA、非GMPグレードプラスミドDNA）、用途別セグメント分析（がん、遺伝性疾患、ウイルス感染症、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、BioReliance、Cobra Biologics、Oxford BioMedica、UniQure、FinVector、MolMed、MassBiologics、Richter-Helm、FUJIFILM Diosynth Biotechnologies、Lonza、Aldevron、Eurogentec、Cell and Gene Therapy Catapult、Biovian、Thermo Fisher Scientific (Brammer Bio)、VGXI、PlasmidFactoryなどが含まれています。世界のプラスミドDNA調製市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、プラスミドDNA調製市場規模を推定する際に考慮しました。本レポートは、プラスミドDNA調製の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、プラスミドDNA調製に関するビジネス上の意思決定に役立てることを目的としています。 ・プラスミドDNA調製市場の概要 - プラスミドDNA調製のタイプ別セグメント - 世界のプラスミドDNA調製市場規模：タイプ別分析（GMPグレードプラスミドDNA、非GMPグレードプラスミドDNA） - プラスミドDNA調製の用途別セグメント - 世界のプラスミドDNA調製市場規模：用途別分析（がん、遺伝性疾患、ウイルス感染症、その他） - 世界のプラスミドDNA調製市場規模予測（2018年-2029年） ・プラスミドDNA調製市場の成長トレンド - プラスミドDNA調製の地域別市場規模（2018年-2029年） - プラスミドDNA調製市場ダイナミクス - プラスミドDNA調製の業界動向 - プラスミドDNA調製市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：GMPグレードプラスミドDNA、非GMPグレードプラスミドDNA - 世界のプラスミドDNA調製のタイプ別市場規模（2018年-2023年） - 世界のプラスミドDNA調製のタイプ別市場規模（2024年-2029年） ・用途別セグメント：がん、遺伝性疾患、ウイルス感染症、その他 - 世界のプラスミドDNA調製の用途別市場規模（2018年-2023年） - 世界のプラスミドDNA調製の用途別市場規模（2024年-2029年） ・プラスミドDNA調製の地域別市場規模 - 北米のプラスミドDNA調製市場規模（2018年-2029年） - アメリカのプラスミドDNA調製市場規模（2018年-2029年） - ヨーロッパのプラスミドDNA調製市場規模（2018年-2029年） - アジア太平洋のプラスミドDNA調製市場規模（2018年-2029年） - 中国のプラスミドDNA調製市場規模（2018年-2029年） - 日本のプラスミドDNA調製市場規模（2018年-2029年） - 韓国のプラスミドDNA調製市場規模（2018年-2029年） - インドのプラスミドDNA調製市場規模（2018年-2029年） - オーストラリアのプラスミドDNA調製市場規模（2018年-2029年） - 中南米のプラスミドDNA調製市場規模（2018年-2029年） - 中東・アフリカのプラスミドDNA調製市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 BioReliance、Cobra Biologics、Oxford BioMedica、UniQure、FinVector、MolMed、MassBiologics、Richter-Helm、FUJIFILM Diosynth Biotechnologies、Lonza、Aldevron、Eurogentec、Cell and Gene Therapy Catapult、Biovian、Thermo Fisher Scientific (Brammer Bio)、VGXI、PlasmidFactory ・アナリストの観点/結論 ・調査方法とデータソース |
Highlights
The global Plasmid DNA Preparation market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Plasmid DNA Preparation is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Plasmid DNA Preparation is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Plasmid DNA Preparation in Cancers is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Plasmid DNA Preparation include BioReliance, Cobra Biologics, Oxford BioMedica, UniQure, FinVector, MolMed, MassBiologics, Richter-Helm and FUJIFILM Diosynth Biotechnologies, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Plasmid DNA Preparation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Plasmid DNA Preparation.
The Plasmid DNA Preparation market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Plasmid DNA Preparation market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Plasmid DNA Preparation companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
BioReliance
Cobra Biologics
Oxford BioMedica
UniQure
FinVector
MolMed
MassBiologics
Richter-Helm
FUJIFILM Diosynth Biotechnologies
Lonza
Aldevron
Eurogentec
Cell and Gene Therapy Catapult
Biovian
Thermo Fisher Scientific (Brammer Bio)
VGXI
PlasmidFactory
Segment by Type
GMP Grade Plasmid DNA
Non-GMP Grade Plasmid DNA
Segment by Application
Cancers
Inherited Disorders
Viral Infections
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Plasmid DNA Preparation companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Plasmid DNA Preparation Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 GMP Grade Plasmid DNA
1.2.3 Non-GMP Grade Plasmid DNA
1.3 Market by Application
1.3.1 Global Plasmid DNA Preparation Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Cancers
1.3.3 Inherited Disorders
1.3.4 Viral Infections
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Plasmid DNA Preparation Market Perspective (2018-2029)
2.2 Plasmid DNA Preparation Growth Trends by Region
2.2.1 Global Plasmid DNA Preparation Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Plasmid DNA Preparation Historic Market Size by Region (2018-2023)
2.2.3 Plasmid DNA Preparation Forecasted Market Size by Region (2024-2029)
2.3 Plasmid DNA Preparation Market Dynamics
2.3.1 Plasmid DNA Preparation Industry Trends
2.3.2 Plasmid DNA Preparation Market Drivers
2.3.3 Plasmid DNA Preparation Market Challenges
2.3.4 Plasmid DNA Preparation Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Plasmid DNA Preparation Players by Revenue
3.1.1 Global Top Plasmid DNA Preparation Players by Revenue (2018-2023)
3.1.2 Global Plasmid DNA Preparation Revenue Market Share by Players (2018-2023)
3.2 Global Plasmid DNA Preparation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Plasmid DNA Preparation Revenue
3.4 Global Plasmid DNA Preparation Market Concentration Ratio
3.4.1 Global Plasmid DNA Preparation Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Plasmid DNA Preparation Revenue in 2022
3.5 Plasmid DNA Preparation Key Players Head office and Area Served
3.6 Key Players Plasmid DNA Preparation Product Solution and Service
3.7 Date of Enter into Plasmid DNA Preparation Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Plasmid DNA Preparation Breakdown Data by Type
4.1 Global Plasmid DNA Preparation Historic Market Size by Type (2018-2023)
4.2 Global Plasmid DNA Preparation Forecasted Market Size by Type (2024-2029)
5 Plasmid DNA Preparation Breakdown Data by Application
5.1 Global Plasmid DNA Preparation Historic Market Size by Application (2018-2023)
5.2 Global Plasmid DNA Preparation Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Plasmid DNA Preparation Market Size (2018-2029)
6.2 North America Plasmid DNA Preparation Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Plasmid DNA Preparation Market Size by Country (2018-2023)
6.4 North America Plasmid DNA Preparation Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Plasmid DNA Preparation Market Size (2018-2029)
7.2 Europe Plasmid DNA Preparation Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Plasmid DNA Preparation Market Size by Country (2018-2023)
7.4 Europe Plasmid DNA Preparation Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Plasmid DNA Preparation Market Size (2018-2029)
8.2 Asia-Pacific Plasmid DNA Preparation Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Plasmid DNA Preparation Market Size by Region (2018-2023)
8.4 Asia-Pacific Plasmid DNA Preparation Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Plasmid DNA Preparation Market Size (2018-2029)
9.2 Latin America Plasmid DNA Preparation Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Plasmid DNA Preparation Market Size by Country (2018-2023)
9.4 Latin America Plasmid DNA Preparation Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Plasmid DNA Preparation Market Size (2018-2029)
10.2 Middle East & Africa Plasmid DNA Preparation Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Plasmid DNA Preparation Market Size by Country (2018-2023)
10.4 Middle East & Africa Plasmid DNA Preparation Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BioReliance
11.1.1 BioReliance Company Detail
11.1.2 BioReliance Business Overview
11.1.3 BioReliance Plasmid DNA Preparation Introduction
11.1.4 BioReliance Revenue in Plasmid DNA Preparation Business (2018-2023)
11.1.5 BioReliance Recent Development
11.2 Cobra Biologics
11.2.1 Cobra Biologics Company Detail
11.2.2 Cobra Biologics Business Overview
11.2.3 Cobra Biologics Plasmid DNA Preparation Introduction
11.2.4 Cobra Biologics Revenue in Plasmid DNA Preparation Business (2018-2023)
11.2.5 Cobra Biologics Recent Development
11.3 Oxford BioMedica
11.3.1 Oxford BioMedica Company Detail
11.3.2 Oxford BioMedica Business Overview
11.3.3 Oxford BioMedica Plasmid DNA Preparation Introduction
11.3.4 Oxford BioMedica Revenue in Plasmid DNA Preparation Business (2018-2023)
11.3.5 Oxford BioMedica Recent Development
11.4 UniQure
11.4.1 UniQure Company Detail
11.4.2 UniQure Business Overview
11.4.3 UniQure Plasmid DNA Preparation Introduction
11.4.4 UniQure Revenue in Plasmid DNA Preparation Business (2018-2023)
11.4.5 UniQure Recent Development
11.5 FinVector
11.5.1 FinVector Company Detail
11.5.2 FinVector Business Overview
11.5.3 FinVector Plasmid DNA Preparation Introduction
11.5.4 FinVector Revenue in Plasmid DNA Preparation Business (2018-2023)
11.5.5 FinVector Recent Development
11.6 MolMed
11.6.1 MolMed Company Detail
11.6.2 MolMed Business Overview
11.6.3 MolMed Plasmid DNA Preparation Introduction
11.6.4 MolMed Revenue in Plasmid DNA Preparation Business (2018-2023)
11.6.5 MolMed Recent Development
11.7 MassBiologics
11.7.1 MassBiologics Company Detail
11.7.2 MassBiologics Business Overview
11.7.3 MassBiologics Plasmid DNA Preparation Introduction
11.7.4 MassBiologics Revenue in Plasmid DNA Preparation Business (2018-2023)
11.7.5 MassBiologics Recent Development
11.8 Richter-Helm
11.8.1 Richter-Helm Company Detail
11.8.2 Richter-Helm Business Overview
11.8.3 Richter-Helm Plasmid DNA Preparation Introduction
11.8.4 Richter-Helm Revenue in Plasmid DNA Preparation Business (2018-2023)
11.8.5 Richter-Helm Recent Development
11.9 FUJIFILM Diosynth Biotechnologies
11.9.1 FUJIFILM Diosynth Biotechnologies Company Detail
11.9.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.9.3 FUJIFILM Diosynth Biotechnologies Plasmid DNA Preparation Introduction
11.9.4 FUJIFILM Diosynth Biotechnologies Revenue in Plasmid DNA Preparation Business (2018-2023)
11.9.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.10 Lonza
11.10.1 Lonza Company Detail
11.10.2 Lonza Business Overview
11.10.3 Lonza Plasmid DNA Preparation Introduction
11.10.4 Lonza Revenue in Plasmid DNA Preparation Business (2018-2023)
11.10.5 Lonza Recent Development
11.11 Aldevron
11.11.1 Aldevron Company Detail
11.11.2 Aldevron Business Overview
11.11.3 Aldevron Plasmid DNA Preparation Introduction
11.11.4 Aldevron Revenue in Plasmid DNA Preparation Business (2018-2023)
11.11.5 Aldevron Recent Development
11.12 Eurogentec
11.12.1 Eurogentec Company Detail
11.12.2 Eurogentec Business Overview
11.12.3 Eurogentec Plasmid DNA Preparation Introduction
11.12.4 Eurogentec Revenue in Plasmid DNA Preparation Business (2018-2023)
11.12.5 Eurogentec Recent Development
11.13 Cell and Gene Therapy Catapult
11.13.1 Cell and Gene Therapy Catapult Company Detail
11.13.2 Cell and Gene Therapy Catapult Business Overview
11.13.3 Cell and Gene Therapy Catapult Plasmid DNA Preparation Introduction
11.13.4 Cell and Gene Therapy Catapult Revenue in Plasmid DNA Preparation Business (2018-2023)
11.13.5 Cell and Gene Therapy Catapult Recent Development
11.14 Biovian
11.14.1 Biovian Company Detail
11.14.2 Biovian Business Overview
11.14.3 Biovian Plasmid DNA Preparation Introduction
11.14.4 Biovian Revenue in Plasmid DNA Preparation Business (2018-2023)
11.14.5 Biovian Recent Development
11.15 Thermo Fisher Scientific (Brammer Bio)
11.15.1 Thermo Fisher Scientific (Brammer Bio) Company Detail
11.15.2 Thermo Fisher Scientific (Brammer Bio) Business Overview
11.15.3 Thermo Fisher Scientific (Brammer Bio) Plasmid DNA Preparation Introduction
11.15.4 Thermo Fisher Scientific (Brammer Bio) Revenue in Plasmid DNA Preparation Business (2018-2023)
11.15.5 Thermo Fisher Scientific (Brammer Bio) Recent Development
11.16 VGXI
11.16.1 VGXI Company Detail
11.16.2 VGXI Business Overview
11.16.3 VGXI Plasmid DNA Preparation Introduction
11.16.4 VGXI Revenue in Plasmid DNA Preparation Business (2018-2023)
11.16.5 VGXI Recent Development
11.17 PlasmidFactory
11.17.1 PlasmidFactory Company Detail
11.17.2 PlasmidFactory Business Overview
11.17.3 PlasmidFactory Plasmid DNA Preparation Introduction
11.17.4 PlasmidFactory Revenue in Plasmid DNA Preparation Business (2018-2023)
11.17.5 PlasmidFactory Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details